BD Spinal Tray Recall Due to Quality Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Becton Dickinson & Company is recalling 5,940 units of BD Spinal Trays nationwide due to quality issues with the included bupivacaine component from a sub-supplier.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 11, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-devices.
What Happened
Becton Dickinson & Company initiated a voluntary recall of certain BD Spinal Trays after a sub-recall from Huons Co, Ltd., the manufacturer of the included Bupivacaine Hydrochloride in Dextrose Injection, USP. The action stems from quality deficiencies related to acceptance testing identified during an FDA manufacturing facility inspection.
Which Products Are Affected
The recall covers BD Spinal Tray with BD Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8.25%), 2 mL (marcaine). Catalog numbers are 405637 and 405707. A total of 5,940 units are affected. Specific lot and UDI details are provided in the recall notice. The products were distributed nationwide to AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, NC, NE, NH, NJ, NV, NY, OH, OR, PA, PR, SD, TN, TX, UT, VA, WA, WI, WV, and WY.
What You Should Do
Consumers and healthcare facilities should refer to the FDA recall notice for lot-specific information and contact Becton Dickinson & Company regarding the affected products.
Why This Matters
This Class I recall involves spinal anesthesia trays distributed across the United States, highlighting ongoing quality control concerns in the supply chain for critical medical components.
Source
FDA recall number Z-2257-2026 (event ID 98842).
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,366 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to July 11, 2026.
Frequently Asked Questions
Common questions about this FDA recall.